ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Vandetanib|DRUG: Cyclophosphamide|DRUG: Methotrexate
Sponsor: Dana-Farber Cancer Institute
Collaborators: AstraZeneca|Massachusetts General Hospital|Brigham and Women's Hospital